A medicine with approval
In the US, medicine review is part of the Food and Drug Administration’s work; its short name is FDA.
Ozempic and Wegovy are brand names for semaglutide; Mounjaro and Zepbound are brand names for tirzepatide. As of September 2026, both medicines have FDA approval for specific uses. Ozempic and Mounjaro treat type 2 diabetes. Wegovy and Zepbound help people lose weight and keep it off.
FDA approval covers a named use after the agency reviews evidence of benefit and harm.
These are examples of approved uses; each medicine’s label gives the full details.